Method of manufacturing ni alloy part
AssigneeIHI Corporation
InventorsNobuyasu Tsuno, Shuji Ikeda
Life of this patent
Estimating the term…
Abstract
A method of manufacturing a Ni alloy part includes a solution treatment step of solution treating a sintered compact, which is obtained by sintering and molding a precipitation hardening Ni alloy powder by metal injection molding, by allowing the sintered compact to hold at a temperature of not lower than 1050° C. but not higher than 1250° C. for one hour to five hours, followed by rapidly cooling to room temperature, where the precipitation hardening Ni alloy powder, and an aging treatment step of aging-treating the solution-treated sintered compact by allowing the solution-treated sintered compact to hold at the temperature of not lower than 600° C. but not higher than 800° C., followed by cooling to room temperature.
Claims4
A method of manufacturing a Ni alloy part comprising
- an aging treatment step of aging-treating a sintered compact, followed by cooling to room temperature without performing a solution treatment,
- wherein the sintered compact is molded from a precipitation hardening Ni alloy powder by metal injection molding with sintering at a temperature of not lower than 1100° C. but not higher than 1250° C. for one hour to five hours, followed by cooling to room temperature at cooling rate equal to or higher than a cooling rate of air cooling without precipitating a δ phase,
- wherein the precipitation hardening Ni alloy powder comprises Ti of 0.65% by mass to 1.15% by mass, inclusive, Al of 0.20% by mass to 0.80% by mass, inclusive, Cr of 17.00% by mass to 21.00% by mass, inclusive, Nb of 4.75% by mass to 5.50% by mass, inclusive, Mo of 2.80% by mass to 3.30% by mass, inclusive, Ni of 50.00% by mass to 55.00% by mass, inclusive, and the balance including Fe and unavoidable impurities, and
- wherein, in the aging treatment step, the sintered compact is allowed to hold at a temperature of 718° C. to 760° C., and then is allowed to hold at 621° C. to 649° C. in a two-step aging treatment without precipitating a δ phase.
Dependencies are inferred from the claim text.